Molecular Staging is 26 yrs old and is based in United States.

Molecular Staging Inc. is a private, life sciences tool company developing a portfolio of technologies for the detection and measurement of proteins and nucleic acids across a broad range of applications, including proteomics, genomics, pharmacogenomics and diagnostics. MSI's core technology is Rolling Circle Amplification Technology (RCAT), an isothermal amplification process for detecting and measuring all classes of biomolecules including protein, DNA, and RNA. RCAT has significant advantages in dynamic range, scalability, sensitivity, multiplexing and flexibility over older methods, such as PCR. RCAT is the only molecular amplification method that aims to allow target recognition, signal amplification, and detection all to be performed directly on a microarray. The technology is compatible with many existing instrument platforms and is ideally suited for multiplexing assays in liquid and solid phase and direct amplification in cells and tissues. MSI is located in New Haven, Connecticut.